RNA
#3510
Atrium Therapeutics, Inc. - Common Stock
13.9 8 USD
+0.01%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+0.94%
Variazione Mensile
+22.52%
Variazione di 6 mesi
+1.23%
Variazione Annuale
-80.12%
Chiusura Precedente
13.8 5
Open
13.9 8
Minimo
13.9 8
Massimo
13.9 8
Volume
12
Financials
- Market Capitalization 239.14 M
- Employee 391
- Founded 2025
- CEO Troy Wilson
- Website www.aviditybiosciences.com
- Headquarter Delaware, United States
- FIGI BBG01Z0T3959
- Industry Biotecnologia
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3489 |  NERV Minerva Neurosciences, Inc - Common Stock | 5.13 USD | -5.52% | +7.10% | +19.86% | +111.98% | 244.94 M USD | ||
| 3493 |  PRQR ProQR Therapeutics N.V. - Ordinary Shares | 2.32 USD | -1.28% | +1.75% | +31.82% | +5.45% | 244.44 M USD | ||
| 3518 |  TARA Protara Therapeutics, Inc. - Common Stock | 3.99 USD | +2.05% | +1.79% | +2.31% | +26.27% | 235.79 M USD | ||
| 3528 |  TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 13.56 USD | -0.59% | +7.88% | +35.60% | -9.66% | 232.57 M USD |